|
2025 Journal Article T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a Phase I trialHawkes, Eliza A., Palmer, Jodie, Khor, Richard, Lee, Sze Ting, Burgess, Melinda, Law, Soi C., Gandhi, Maher K., Chong, Geoffrey, Shortt, Jake, Chowdhury, Rakin, Swain, Fiona, Churilov, Leonid, MacManus, Michael M., Smith, Charmaine, Scott, Fiona Elizabeth, Martynchyk, Arina, Barraclough, Allison, Manos, Kate, Scott, Andrew M. and Keane, Colm (2025). T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a Phase I trial. Blood Advances, 9 (20), 5263-5273. doi: 10.1182/bloodadvances.2025016505 |
|
2025 Conference Publication POSTER: ABCL-1487 Large B-Cell Lymphoma Microenvironment Archetype Profiles (LymphoMAPs) Clinically Identify Subgroups With Greatest Benefit From CD19 CAR T-Cell TherapyLi, Xubin, Singhal, Kartik, Deng, Qing, Chihara, Dai, Russler-Germain, David A., Hussein, Usmana, Foltz, Jennifer A., Henderson, Jared, Wilson, Ashley, Tobin, Joshua, Gandhi, Maher K., Schmidt, Evelyn, Nizamuddin, Imran, Dinh, Tommy, Sun, Ryan, Kesaraju, Akhil, Hilton, Laura, Scott, David W., Vega, Francisco, Flowers, Christopher, Griffith, Obi, Fehniger, Todd A., Griffith, Malachi, Green, Michael R., Harkins, Andrew, Arita, Kotaro, Kizhakeyil, Atish, Lakra, Priya, Hamilton, Mark P. ... Westin, Jason R. (2025). POSTER: ABCL-1487 Large B-Cell Lymphoma Microenvironment Archetype Profiles (LymphoMAPs) Clinically Identify Subgroups With Greatest Benefit From CD19 CAR T-Cell Therapy. Society of Hematologic Oncology Thirteenth Annual Meeting, Houston, TX United States, 3-6 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)01097-3 |
|
2025 Conference Publication Large B-Cell Lymphoma Microenvironment Archetype Profiles (LymphoMAPs) Clinically Identify Subgroups With Greatest Benefit From CD19 CAR T-Cell TherapyLi, Xubin, Singhal, Kartik, Deng, Qing, Chihara, Dai, Russler-Germain, David A., Hussein, Usmana, Foltz, Jennifer A., Henderson, Jared, Wilson, Ashley, Tobin, Joshua, Gandhi, Maher K., Schmidt, Evelyn, Nizamuddin, Imran, Dinh, Tommy, Sun, Ryan, Kesaraju, Akhil, Hilton, Laura, Scott, David W., Vega, Francisco, Flowers, Christopher, Griffith, Obi, Fehniger, Todd A., Griffith, Malachi, Green, Michael R., Harkins, Andrew, Arita, Kotaro, Kizhakeyil, Atish, Lakra, Priya, Hamilton, Mark P. ... Westin, Jason R. (2025). Large B-Cell Lymphoma Microenvironment Archetype Profiles (LymphoMAPs) Clinically Identify Subgroups With Greatest Benefit From CD19 CAR T-Cell Therapy. Society of Hematologic Oncology Thirteenth Annual Meeting, Houston, TX United States, 3-6 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)02385-7 |
|
2025 Journal Article Large B cell lymphoma microenvironment archetype profilesLi, Xubin, Singhal, Kartik, Deng, Qing, Chihara, Dai, Russler-Germain, David, Harkins, R. Andrew, Henderson, Jared, Arita, Kotaro, Kizhakeyil, Atish, Sun, Ryan, Lakra, Priya, Hussein, Usama, Foltz, Jennifer A., Wilson, Ashley, Schmidt, Evelyn, Nizamuddin, Imran, Dinh, Tommy, Kesaraju, Akhil, Hamilton, Mark P., Allen, Carl, Gandhi, Maher K., Tobin, Joshua, Jiang, Aixiang, Hilton, Laura, Scott, David W., Vega, Francisco, Flowers, Christopher R., Westin, Jason R., Griffith, Obi L. ... Green, Michael R. (2025). Large B cell lymphoma microenvironment archetype profiles. Cancer Cell, 43 (7), 1347-1364.e13. doi: 10.1016/j.ccell.2025.06.002 |
|
2025 Conference Publication Large B‐cell lymphoma microenvironment archetype profiles (lymphomaps) identify subgroups with greatest benefit from CD19 car T‐cell therapyRussler‐Germain, D. A, Li, X., Singhal, K., Deng, Q., Chihara, D., Hussein, U., Foltz, J. A, Henderson, J., Wilson, A., Tobin, J., Gandhi, M. K, Schmidt, E., Nizamuddin, I., Dinh, T., Sun, R., Kesaraju, A., Hilton, L., Scott, D. W, Vega, F., Flowers, C. R, Westin, J. R, Griffith, O. L, Fehniger, T. A, Griffith, M. and Green, M. R (2025). Large B‐cell lymphoma microenvironment archetype profiles (lymphomaps) identify subgroups with greatest benefit from CD19 car T‐cell therapy. 18th International Conference on Malignant Lymphoma, Lugano, Switzerland, 17 ‐ 21 June 2025. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1002/hon.70093_5 |
|
2025 Book Chapter The Epstein-Barr Virus in Classical Hodgkin Lymphoma: Pathogenesis, Immunobiology, and Therapeutic ImplicationsGandhi, Maher K. and Murray, Paul (2025). The Epstein-Barr Virus in Classical Hodgkin Lymphoma: Pathogenesis, Immunobiology, and Therapeutic Implications. Current Topics in Microbiology and Immunology. (pp. 1-21) Berlin, Heidelberg: Springer Berlin Heidelberg. doi: 10.1007/82_2025_324 |
|
2024 Journal Article Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphomaMacManus, Michael P., Seymour, John F., Tsang, Hennes, Fisher, Richard, Keane, Colm, Sabdia, Muhammed B., Law, Soi C., Gunawardana, Jay, Nath, Karthik, Kazakoff, Stephen H., Marques-Piubelli, Mario L., Duenas, Daniela E., Green, Michael R., Roos, Daniel, O'Brien, Peter, McCann, Andrew, Tsang, Richard, Davis, Sidney, Christie, David, Cheah, Chan, Amanuel, Benhur, Cochrane, Tara, Butler, Jason, Johnston, Anna, Shanavas, Mohamed, Li, Li, Vajdic, Claire, Kridel, Robert, Shelton, Victoria ... Tobin, Joshua W. D. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma. eBioMedicine, 110 105468, 1-13. doi: 10.1016/j.ebiom.2024.105468 |
|
2024 Conference Publication Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at RelapseSwain, Fiona, Burgess, Melinda, Kempe, Sarah, Sabdia, Muhammed B., Henden, Andrea S., Wight, Joel, Hawkes, Eliza A., Mutsando, Howard, Talaulikar, Dipti, Merida de Long, Lilia, Birch, Simone, Wyche, Penelope, Hawula, Zachary, Chowdhury, Rakin, Gandhi, Maher K. and Keane, Colm (2024). Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-199352 |
|
2024 Journal Article Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapyHershenfeld, Samantha A., Tobin, Josuha W. D., Shelton, Victoria, Calvente, Lourdes, Lajkosz, Katherine, Liu, Ting, Brodtkorb, Marianne, d'Amore, Francesco Annibale, Ludvigsen, Maja, Baetz, Tara, LeBrun, David, Johnson, Nathalie, Crump, Michael, Hong, Michael, Kuruvilla, John, Tremblay-LeMay, Rosemarie, MacManus, Michael, Tsang, Richard, Hodgson, David C., Gandhi, Maher K. and Kridel, Robert (2024). Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy. British Journal of Haematology, 205 (5), 1810-1814. doi: 10.1111/bjh.19698 |
|
2024 Journal Article Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG studyVerner, Emma, Johnston, Amanda, Pati, Nalini, Hawkes, Eliza A., Lee, Hui-Peng, Cochrane, Tara, Cheah, Chan Yoon, Filshie, Robin, Purtill, Duncan, Sia, Hanlon, Enjeti, Anoop K., Brown, Christina, Murphy, Nicholas, Curnow, Jennifer, Lee, Kenneth, Gandhi, Maher K., Walia, Mannu, Butcher, Belinda E. and Trotman, Judith (2024). Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study. Blood Advances, 8 (21), 5674-5682. doi: 10.1182/bloodadvances.2024014035 |
|
2024 Conference Publication Cancer incidence and survival statistics by histological type: A new approach for reporting cancer data in Australia by the Australian Institute of Health and WelfareShort, Mark, Cooke-Yarborough, Claire, Bufton, Brent, Hatsiz, Christina, Wong, Henry, Harvey, Justin, Erber, Wendy and Gandhi, Maher (2024). Cancer incidence and survival statistics by histological type: A new approach for reporting cancer data in Australia by the Australian Institute of Health and Welfare. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD, Australia, 13 - 15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2024 Journal Article Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphomaGunawardana, Jay, Law, Soi C., Sabdia, Muhammed B., Fennell, Éanna, Hennessy, Aoife, Leahy, Ciara I., Murray, Paul G., Bednarska, Karolina, Brosda, Sandra, Trotman, Judith, Berkahn, Leanne, Zaharia, Andreea, Birch, Simone, Burgess, Melinda, Talaulikar, Dipti, Lee, Justina N., Jude, Emily, Hawkes, Eliza A., Jain, Sanjiv, Nath, Karthik, Snell, Cameron, Swain, Fiona, Tobin, Joshua W. D., Keane, Colm, Shanavas, Mohamed, Blyth, Emily, Steidl, Christian, Savage, Kerry, Farinha, Pedro ... Gandhi, Maher K. (2024). Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma. American Journal of Hematology, 99 (11), 2096-2107. doi: 10.1002/ajh.27459 |
|
2024 Journal Article The Post-transplant Lymphoproliferative Disorders—Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) study methods and protocolDharnidharka, Vikas R., Wylie, Kristine M., Wylie, Todd N., Ruzinova, Marianna B., Goss, Charles W., Storch, Gregory A., Mehta-Shah, Neha, Byers, Derek, Walther, Leslie, Jaza, Lujain, Gu, Hongjie, Agarwal, Mansi, Green, Michael, Moore, Erika, Swerdlow, Steven H., Silveira, Fernanda, Marks, Lianna J., Gratzinger, Dita, Bagg, Adam, Law, Soi Cheng and Gandhi, Maher (2024). The Post-transplant Lymphoproliferative Disorders—Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) study methods and protocol. Transplantation Direct, 10 (11) e1723, 1-9. doi: 10.1097/txd.0000000000001723 |
|
2024 Journal Article Systemic diffuse large B-cell lymphoma involving the central nervous system have high rates of defective antigen presentation and immune surveillanceWight, Joel, Blombery, Piers, Lickiss, Jennifer, Burgess, Melinda, Gould, Clare, Minson, Adrian, Swain, Fiona, Sabdia, Muhammed B., Gandhi, Maher K., Birchley, Andrew, Keane, Colm and Hawkes, Eliza A. (2024). Systemic diffuse large B-cell lymphoma involving the central nervous system have high rates of defective antigen presentation and immune surveillance. Haematologica, 109 (9), 3013-3018. doi: 10.3324/haematol.2023.284600 |
|
2024 Journal Article Identification of genetic subtypes in follicular lymphomaShelton, Victoria, Detroja, Rajesh, Liu, Ting, Isaev, Keren, Silva, Anjali, Passerini, Verena, Bakhtiari, Mehran, Calvente, Lourdes, Hong, Michael, He, Michael Y., Modi, Saloni, Hershenfeld, Samantha A., Ludvigsen, Maja, Madsen, Charlotte, Hamilton-Dutoit, Stephen, d’Amore, Francesco Annibale, Brodtkorb, Marianne, Johnson, Nathalie A., Baetz, Tara, LeBrun, David, Tobin, Josh W. D., Gandhi, Maher K., Mungall, Andrew J., Xu, Wei, Ben-Neriah, Susana, Steidl, Christian, Delabie, Jan, Tremblay-LeMay, Rosemarie, Jegede, Opeyemi ... Kridel, Robert (2024). Identification of genetic subtypes in follicular lymphoma. Blood Cancer Journal, 14 (1) 128, 1-13. doi: 10.1038/s41408-024-01111-w |
|
2024 Journal Article Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapyCasey, Mika, Lee, Carol, Hoyte, Sharon M., Johnston, Rebecca L., Kwok, Wing Yu, Law, Soi Cheng, Gandhi, Maher K., Harrison, Simon J. and Nakamura, Kyohei (2024). Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy. Haematologica, 109 (7), 2131-2143. doi: 10.3324/haematol.2023.284435 |
|
2024 Journal Article EBNA2: a viral maestra conducting a symphony orchestraGandhi, Maher K. and Kelly, Gemma L. (2024). EBNA2: a viral maestra conducting a symphony orchestra. Blood, 143 (5), 384-385. doi: 10.1182/blood.2023022744 |
|
2024 Journal Article Epstein–Barr virus‐associated lymphomas decodedBednarska, Karolina, Chowdhury, Rakin, Tobin, Joshua W. D., Swain, Fiona, Keane, Colm, Boyle, Stephen, Khanna, Rajiv and Gandhi, Maher K. (2024). Epstein–Barr virus‐associated lymphomas decoded. British Journal of Haematology, 204 (2), 415-433. doi: 10.1111/bjh.19255 |
|
2024 Journal Article EBV-infected hematopoietic stem cells drive CAEBVKhanna, Rajiv and Gandhi, Maher K. (2024). EBV-infected hematopoietic stem cells drive CAEBV. Blood, 143 (1), 2-4. doi: 10.1182/blood.2023022739 |
|
2024 Journal Article The IRE1α endonuclease plays a dual role in regulating the XBP1/miRNA-34a axis and PD-1 Expression within natural killer cells in Hodgkin lymphomaBednarska, Karolina, Thillaiyampalam, Gayathri, Mujaj, Sally, Nourse, Jamie, Gunawardana, Jay, Sabdia, Muhammed B., Law, Soi C., Pilaar, Anna, Cui, Qingyan, de Long, Lilia M., Vari, Frank, Gandhi, Maher K. and Cristino, Alexandre S. (2024). The IRE1α endonuclease plays a dual role in regulating the XBP1/miRNA-34a axis and PD-1 Expression within natural killer cells in Hodgkin lymphoma. Acta Haematologica, 147 (6), 1-16. doi: 10.1159/000536044 |
